![Marco Taglietti](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marco Taglietti
Directeur/Membre du Conseil chez
BIOSERGEN AB
Fortune : - $ au 30/06/2026
Profil
Marco Taglietti is currently an Independent Director at Aquestive Therapeutics, Inc. since 2021, a Director at Biosergen AB starting in 2025, a Director at Aurobac Therapeutics SAS since 2023, a Director at the American Foundation for Suicide Prevention, and a Director at Orchestra of St Lukes Support Corp.
since 2019.
Former roles include President, Chief Executive Officer & Director at SCYNEXIS, Inc. from 2015 to 2022; Independent Director at Delcath Systems, Inc. from 2014 to 2021; Independent Director at Medpace Research, Inc. from 2014 to 2017; Director at HealthCare Institute of New Jersey from 2011 to 2014; Director at Transcelerate Biopharma, Inc. from 2013 to 2014; Director at BioNJ, Inc. from 2016 to 2023; Chief Medical Officer & EVP-Research & Development at Forest Laboratories, Inc. from 2013 to 2014; SVP, Head-Global Research & Development at Stiefel Laboratories, Inc. from 2004 to 2007; Vice President at Schering-Plough Research Institute from 1992 to 2009; President at Forest Research Institute, Inc. from 2007 to 2014; and other vice president roles at Schering-Plough Corp.
and Worldwide Clinical Research, Inc. Education includes undergraduate studies at the University of Pavia.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 02/04/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Marco Taglietti
| Sociétés | Poste | Début |
|---|---|---|
| AQUESTIVE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 10/02/2021 |
| BIOSERGEN AB | Directeur/Membre du Conseil | 11/06/2025 |
American Foundation for Suicide Prevention
 American Foundation for Suicide Prevention Miscellaneous Commercial ServicesCommercial Services Operates as a voluntary health organization that dedicated to saving lives and bringing hope to those affected by suicide | Directeur/Membre du Conseil | - |
Orchestra of St. Luke's
 Orchestra of St. Luke's Orchestra of St Lukes Support Corp. is a non-profit company based in New York, NY. | Directeur/Membre du Conseil | 01/01/2019 |
Aurobac Therapeutics SAS
 Aurobac Therapeutics SAS Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for bacterial infections | Directeur/Membre du Conseil | 01/01/2023 |
Anciens postes connus de Marco Taglietti
| Sociétés | Poste | Fin |
|---|---|---|
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes the biotechnology industry in New Jersey | Directeur/Membre du Conseil | 01/01/2023 |
| SCYNEXIS, INC. | Directeur Général | 31/12/2022 |
| DELCATH SYSTEMS, INC. | Directeur/Membre du Conseil | 11/05/2021 |
| NEPHROGENEX INC | Directeur/Membre du Conseil | 01/01/2017 |
| ░░░░░░ ░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Marco Taglietti
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
71
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells drug products | Health Technology |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Delcath Systems, Inc.
 Delcath Systems, Inc. Medical SpecialtiesHealth Technology Develops and manufactures drugs for treatment of cancer | Health Technology |
Aquestive Therapeutics, Inc.
 Aquestive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes thin film pharmaceutical and over the counter drug products | Health Technology |
SCYNEXIS, Inc.
 SCYNEXIS, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections | Health Technology |
Medpace Research, Inc.
 Medpace Research, Inc. Medical DistributorsDistribution Services Develops drugs and novel therapies for kidney diseases | Distribution Services |
Stiefel Laboratories, Inc.
 Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Pavia
 University of Pavia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Foundation for Suicide Prevention
American Foundation for Suicide Prevention Miscellaneous Commercial ServicesCommercial Services Operates as a voluntary health organization that dedicated to saving lives and bringing hope to those affected by suicide | Commercial Services |
HealthCare Institute of New Jersey
 HealthCare Institute of New Jersey The HealthCare Institute of New Jersey is a trade association representing research-based biopharmaceutical, medical device, and diagnostic companies. The private company is based in Bridgewater, NJ. It advocates for policies that promote innovation, patient access to advanced medical products, and job creation within the life sciences sector. The organization collaborates with government, academia, and stakeholders to foster an innovation ecosystem and raise awareness of the industry’s clinical, economic, and social impact. It emphasizes corporate social responsibility, including commitments to philanthropy, environmental sustainability, ethical practices, and community engagement. The institute leads initiatives in diversity, equity, and inclusion, aiming to transform corporate culture, diversify supply chains, and address health inequities. It provides patient advocacy and assistance programs, such as the rx4nj partnership and njsave, which connect patients to prescription assistance and other support programs. Christine Buteas has been the CEO of the company since 2024. | |
Schering-Plough Research Institute
 Schering-Plough Research Institute Medical SpecialtiesHealth Technology Provides pharmaceutical research | Health Technology |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes the biotechnology industry in New Jersey | Commercial Services |
Forest Research Institute, Inc. | |
Worldwide Clinical Research, Inc.
 Worldwide Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services to the clinical research industry | Commercial Services |
Orchestra of St. Luke's
Orchestra of St. Luke's Orchestra of St Lukes Support Corp. is a non-profit company based in New York, NY. | |
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Provides biopharmaceutical research services | Health Technology |
Biosergen AB
 Biosergen AB BiotechnologyHealth Technology Operates as a biotechnology company that develops antifungal drugs | Health Technology |
Aurobac Therapeutics SAS
Aurobac Therapeutics SAS Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for bacterial infections | Health Technology |
